WHOOP is leveling up.
What’s happening: The wearable company closed a $575M Series G led by Collaborative Fund, reaching a $10.1B valuation as it pushes deeper into personalized, preventative health.
Adding strategic backing, the round includes Abbott and Mayo Clinic, plus high-profile investors like Cristiano Ronaldo, LeBron James, and Rory McIlroy — reinforcing WHOOP’s relevance across performance, healthcare, and culture.
Fast track. WHOOP now counts more than 2.5M members worldwide. In 2025, sales grew 103% YoY, reaching a $1.1B run rate, with the company remaining cash flow positive.
Thinking globally, the new capital will fuel expansion across Europe, the GCC, Latin America, and Asia, with WHOOP hiring 600+ roles to support R&D and international growth.
Upgraded. WHOOP is moving beyond fitness tracking toward a more unified health platform — combining wearable data, AI, ECG, blood pressure insights, longevity features, and Advanced Labs into a single system designed to extend healthspan and prevent disease.
Powered by 24B+ hours of physiological data, WHOOP says members open the app more than eight times per day on average, using it to connect sleep, recovery, strain, nutrition, and stress with long-term health outcomes.
Arms race. With Oura fresh off a $900M+ raise and eyeing an IPO, the wearables race is shifting from product launches to public markets. WHOOP is charting a similar path, meaning whoever goes out first could set financial benchmarks for the category — shaping how investors evaluate growth, retention, and platform potential.
Punchline: With fresh capital, strategic healthcare backing, and international momentum, WHOOP is racing to fulfill its vision for a Personal Health OS.
